1 Day
Source:
جراءة نيوز
Updated guidelines on respiratory virus vaccines
A coalition comprising leading medical groups has issued its own recommendations regarding respiratory virus vaccines for the 2026-2027 seasons, based on an independent review of available evidence and data. The American Medical Association (AMA) recommends that all children aged 6 months and older receive the influenza vaccine, and that children between 6 and 23 months old receive the COVID-19 vaccine. Additionally, children aged two to 18 years, especially those in vulnerable groups, are advised to get the vaccines appropriate for their age. The coalition also recommends administering the Respiratory Syncytial Virus (RSV) vaccine to newborns who have not acquired immunity before birth, as well as to children aged 8 to 19 months within at-risk groups. The findings confirm that vaccination provides effective protection against hospitalization, severe illness, and death, with no new safety concerns observed, and that the results are consistent with the known safety profiles of these vaccines.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)